Activity of grepafloxacin against respiratory isolates ofStreptococcus pneumoniae

  • A. P. Johnson
  • M. Warner
  • T. Parsons


Sparfloxacin Prosthetic Joint Infection Floxacin Grepafloxacin Tosufloxacin 


  1. 1.
    Applebaum PC: Antimicrobial resistance inStreptococcus pneumoniae: an overview. Clinical Microbiology Reviews 1992, 15: 77–83.Google Scholar
  2. 2.
    Johnson AR, Speller DCE, George RC, Warner M, Domingue G, Efstratiou A: Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. British Medical Journal 1996, 312: 1454–1456.PubMedGoogle Scholar
  3. 3.
    National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd Edition. Approved Standard, M7-A3. NCCLS, Villanova, PA, 1993.Google Scholar
  4. 4.
    Imada T, Miyazaki S, Nishida M, Yamaguchi K, Goto S: In vitro and in vivo antimicrobial activities of a new quinolone, OPC-17116. Antimicrobial Agents and Chemotherapy 1992, 36: 573–579.PubMedGoogle Scholar
  5. 5.
    Sader HS, Erwin ME, Jones RN: In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 372–381.CrossRefGoogle Scholar
  6. 6.
    Pankuch GA, Jacobs MR, Appelbaum PC: Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 1995, 35: 230–232.PubMedGoogle Scholar

Copyright information

© MMV Medizin Verlag GmbH 1997

Authors and Affiliations

  • A. P. Johnson
    • 1
  • M. Warner
    • 1
  • T. Parsons
    • 1
  1. 1.Antibiotic Reference Unit, Laboratory of Hospital InfectionCentral Public Health LaboratoryLondonUK

Personalised recommendations